A Phase 1 Clinical Study of ABX-EGF (Panitumumab) Evaluation of the Safety and Pharmacokinetics of ABX-EGF in Japanese Subjects with Advanced Solid Tumors

Sponsor ID

20040192

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

N/A

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.